New research suggests that early life factors could increase prostate cancer risk

7 April 2016

Factors that influence when boys go through puberty could affect a man’s future risk of developing prostate cancer, a large study funded by World Cancer Research Fund has found[1].

For the first time, sexual maturation was assessed using genetic markers and the study, published in the journal BMC Medicine, found that these early puberty genes were associated with an increased risk of prostate cancer in later life.

Genes that could indicate sexual maturation were identified and each man was given a score dependent on how many of these maturity genes were present.  Measuring sexual maturation in this way allows for a possible causal link to be drawn between reaching puberty early and an increased risk of prostate cancer. This method also is more reliable than the conventional use of physical pubertal changes, which are imprecise and difficult to isolate.

The link between genetic factors that influence when boys enter puberty and prostate cancer could be due to the effect of early and prolonged increased levels of growth hormones which are altered with puberty, although this remains to be examined.

Prostate cancer is the most common cancer in men in the UK with over 47,000 new cases each year. Over 10,000 men die of the cancer each year. Worldwide it is the second most common cancer in men[2].

Dr Panagiota Mitrou, Director of Research Funding at World Cancer Research Fund, said:

“These results are very exciting as they show evidence of life course influences on prostate cancer risk including the aggressive form of the disease.

“We now need to better understand the findings. If growth factor hormones are shown to be the driving force behind age of puberty and prostate cancer risk and progression, they could help us develop dietary interventions to promote healthy growth and hence protect against prostate cancer in adulthood.

“There are however other ways that men can help reduce their prostate cancer risk, such as maintaining a healthy weight”. 

Professor David Neal, study principal investigator at the University of Cambridge, said:

“This is the first time genetic markers have been used to measure sexual maturation. The research is particularly interesting because it has demonstrated a new way to look at risk factors which allows more potential cause and effect relationships to be established.

“With prostate cancer being the most common cancer in men in the UK, prevention is key if we are to see a decrease in the number of men developing the disease.”

Professor Richard Martin, study researcher at the University of Bristol, said:

“There are still many unanswered questions around what could prevent prostate cancer. However, these results linking sexual maturation and prostate cancer risk could help fill some of the gaps in our knowledge.

“What might be linking earlier age of puberty with the increased risk of prostate cancer are the effects of growth factor hormones and male sex hormones, which should be examined more closely in future research”.

ENDS

For more information contact:

Melanie Purnode, Press and PR Manager, WCRF on 020 343 4273 or pr@wcrf.org

Notes to editors:

About the research

Epidemiological studies have observed a link between an earlier age of sexual development and having a higher prostate cancer risk, but markers of sexual maturation in boys are often imprecise. This study used genetic markers to score sexual maturation, allowing a cause and effect link to be drawn. 2,927 participants took part, who were already enrolled in a prostate cancer study called ProtecT, and the study was replicated with 43,737 participants from a consortium of studies known as PRACTICAL.

About World Cancer Research Fund

For the past 25 years, World Cancer Research Fund has been the UK’s leading charity dedicated to the prevention of cancer through diet, weight and physical activity. By funding and supporting research, developing policy recommendations and providing health information, we have ensured that people can make informed lifestyle choices to reduce their risk of developing a preventable cancer. As we look forward to our next 25 years, our scientific research ensures that we will continue to have the latest and most authoritative information at our fingertips, all underpinned by independent expert advice.

Our analysis of global research shows that a third of the most common cancers are preventable through a healthy diet, maintaining a healthy weight and regular physical activity.

For more information visit www.wcrf-uk.org, follow us on Twitter at http://twitter.com/wcrf_uk, read our blog at http://wcrf-uk.org/uk/blog or visit our Facebook page at http://www.facebook.com/wcrfuk

About the University of Bristol

The University of Bristol is one of the most popular and successful universities in the UK. It was ranked within the top 40 universities in the world in the QS World University rankings 2015 and 9th in the country. The University of Bristol is ranked among the top five institutions in the UK for its research, according to new analysis of the Research Excellence Framework (REF) 2014.

Bristol is a member of the Russell Group of UK research-intensive universities, and a member of the Worldwide Universities Network, a grouping of research-led institutions of international standing.

The University was founded in 1876 and was granted its Royal Charter in 1909.  It was the first university in England to admit women on the same basis as men. 

The University is a major force in the economic, social and cultural life of Bristol and the region, but is also a significant player on the world stage. It has over 16,000 undergraduates and nearly 6,000 postgraduate students from more than 100 countries, and its research links span the globe.

Twelve Bristol graduates and members of staff have been awarded Nobel Prizes, including Sir Winston Churchill who was Chancellor of the University of Bristol from 1929 until 1965.

[1] Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort, Bonilla et al. BMC Medicine, 2016.

 http://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-016-0602-x

[2] Globocan, 2012: http://globocan.iarc.fr/Pages/fact_sheets_population.aspx